Free CE/CME Activities
Browse free continuing education activities across medical specialties
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
Available through August 30, 2026
Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP
A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management
Available through August 30, 2026
David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD
Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment
Available through August 30, 2026
Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD
The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice
Available through August 30, 2026
Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS
Collaborating Across the Continuum™: The Pediatrician’s Vital Role in Multidisciplinary Management of Pediatric PAH
Cardiology, New Drugs, Pediatrics, Pulmonology
Available through August 30, 2026
Jean M. Elwing, MD, FCCP; Russel Hirsch, MD; John F. Morehous, MD
Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management
Available through August 30, 2026
Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD
Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm
Available through August 29, 2026
Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD
Burst CME: Managing Fluid Overload in Patients with Chronic Kidney Disease (Part 2)
Available through August 16, 2026
Suneel Udani, MD
Burst CME: Managing Fluid Overload in Patients with Chronic Kidney Disease (Part 1)
Available through August 1, 2026
Suneel Udani, MD
Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease
Available through August 1, 2026
SriniVas Sadda, MD, FARVO; Nathan Steinle, MD
Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis
Available through August 1, 2026
Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD











